Dr. Cai is Doctor of Medicine from Tongji Medical College, Huazhong University of Science and Technology. Dr. Cai began conceptualizing and designing recombinant Coxsackievirus B3 in 2010, and led a research and development team to tackle the construction, preparation process, and quality standards of recombinant Coxsackievirus B3, making recombinant Coxsackievirus B3 injection a potent anti-tumor drug and providing new directions for the development and utilization of oncolytic drugs.